chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Complete body aches and pains by 2:30 AM. Headache was very bad at 3:30 AM that required treating with Tylenol, but as I was getting a glass of water to wash down the medication, I passed out and fell to the floor. being so early in the morning, the rest of the family was sound asleep on the second floor.  Eventually I did manage to get to the couch.  Later in the morning, my husband helped me to the bedroom on the second floor.  By the time we reached the top of the steps, I could feel myself almost close to passing out again.  This would occur every time I tried to sit or stand throughout the day on 9-12-21.  I could not get fluids in nor did I have an appetite.  The extreme hot and cold chills would come at the same time.  Taking 1000 mg of Tylenol every six hours barely blocked the pain. By Sunday evening, my neck became very stiff and sore to where I could not turn my head of touch my chin to my chest. Every rib felt like it had been hit by a board. Then the back spasms started in my lower back. This combination continued well into Monday (9-13-21) where  I had to call in to work and tell them I was not able to come in.  By late Monday I was able to sit up for short periods of time and stand very short periods of time before I had to lie back down.  I was able to start getting fluids in more Monday and eat a small portion of food. Tuesday (9-14-21) I had to report to work, which was difficult as I still had a hard time turning my head from side to side. Dizziness and headaches were par for the course all day. I did not stay at work long and had to leave before the end of the day.
When my fever, chill and joint and skin ache lessened my chest (lungs) started hurting. Hard to breathe.
Moderna COVID?19 Vaccine EUA  Extreme difficulty breathing. Started earlier in the day. Hospitalized within 3 hours of onset. Breathing difficulties relieved somewhat prior to hospitalization by administration of two puffs of ProAir HFA.   Experienced extreme abdominal pain.   Hospital administered Albuterol, contact hospital for dose.
PATIENT REPORTS WEIGHT GAIN (30 + LBS) PAIN AND BURNING IN FEET "WIPED OUT IMMUNE SYSTEM
p/vax pt broke out in a full blown case of chickenpox w/a rash that covered whole body, especially feet;also febrile & lethargic;pt seen by MD who felt that events were not r/t vax;
allergic reaction; her arm was hurting; she felt very dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 11Feb2021 (Batch/Lot number: unknown) at the age of 73 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 11Feb2021, outcome "unknown", described as "she felt very dizzy"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "allergic reaction"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "her arm was hurting". Additional information: The patient and her husband received the first dose of the Pfizer Covid 19 vaccine on 11Feb2021. She felt very dizzy. She stated when they received the call for the second dose, she explained all this and was told not to get the second dose since they experienced an allergic reaction and to call to report it. It was also reported that her arm was hurting when given the vaccine. Patient was querying if they can be provided a card or letter explaining or saying they were allergic and can't get the second one so they can travel to another country.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021243669 Same reporter and product; similar events; different patient
1st of the vaccine I only felt sore arm. After 24 to 48 hours, I started having Diarrhea, it didn't last long but it was probably the worst I ever had( green ). Later, I had stomach pain for a few hours. And felt tired for a while, around 2 days. I've had a few drinks the night before the symptoms started showing up, but I didn't have anything similar before, so it's most likely related to vaccine.
42 y/o nurse was administered the vaccine to a patient (she did not receive the vaccine). She presented to employee health with redness on bilateral arms, neck, and lower jaw. She stated it was itchy but starting to improve. She has had similar reactions in the past when giving the vaccine.
Right arm became significantly swollen with a red, warm, hard area at the injection site that had small water blisters that formed. Left side of back developed blotchy patches.
Site of the injection it is bumpy; Site of the injection a little itchy; Site of the injection it is red; Painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful), VACCINATION SITE MASS (Site of the injection it is bumpy), VACCINATION SITE PRURITUS (Site of the injection a little itchy) and VACCINATION SITE ERYTHEMA (Site of the injection it is red) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Painful). On an unknown date, the patient experienced VACCINATION SITE MASS (Site of the injection it is bumpy), VACCINATION SITE PRURITUS (Site of the injection a little itchy) and VACCINATION SITE ERYTHEMA (Site of the injection it is red). At the time of the report, PAIN IN EXTREMITY (Painful) had resolved and VACCINATION SITE MASS (Site of the injection it is bumpy), VACCINATION SITE PRURITUS (Site of the injection a little itchy) and VACCINATION SITE ERYTHEMA (Site of the injection it is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Injection side pain; Tiredness; Headache; Muscle pain; Chills; Fever; Feeling unwell; This is a spontaneous report from a non-contactable other healthcare professional. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0183) via an unspecified route of administration in the left arm on 11May2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0170) via an unspecified route of administration in the left arm on 16Apr2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021 at 22:00, the patient experienced injection side pain, tiredness, headache, muscle pain, chills, fever and felt unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events injection side pain, tiredness, headache, muscle pain, chills, fever and feeling unwell were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Also felt a mucus feeling in the back of my throat; I had a strange taste in the back of my throat; This is a spontaneous report from a contactable consumer (Patient). This consumer reported in response to Non-HCP follow-up letter sent in cross-referenced case which included Patient Age at Time of Vaccination in Months: or Years: 50. This is the second of the two cases.  A 50-year-old female patient received second dose of BNT162B2 (Pfizer COVID-19 Vaccine, solution for injection, lot number: EK9231; Expiration Date: 30Apr2021), via an unspecified route of administration on 08Jan2021 (at the age of 50-years-old) as single dose for COVID-19 immunisation. Medical history included ongoing mild dog allergies and takes occasional Claritin, ongoing dust allergies and takes occasional Claritin. Patient had wheezing after taking intrauterine contrast dye in 2014 that lasted for about 30 min, and required Albuterol. There were no concomitant medications. The patient previously took first dose of BNT162B2 (Pfizer COVID-19 Vaccine, solution for injection, lot number: EH9899; Expiration Date: 31Mar2021), via an unspecified route of administration on 19Dec2020 (at 09:00 (24 hour clock) Approximate) as single dose for COVID-19 immunisation and at 09:05, experienced feeling of swelling of the upper lip and throat, brief tongue tingling, palms felt sweaty/felt sweaty, throat felt dry, mildly dizzy, strange taste feeling in the back of my throat and patient treated with Benadryl and Claritin. The patient visited allergist where she was informed that she does not have any allergic reaction. The patient took Claritin the night prior ans that day (Forward arrow sign) No feeling of swelling of lip or tingling. On an unspecified date, patient had a strange taste in the back of throat but none of the other symptoms. It started a few minutes after + lasted about 1 minute. On an unspecified date, patient had mucus feeling in the back of throat, but this may be due to chronic allergies to dog/dust. The patient's allergist did not feel that patient had an allergic reaction. The outcome of the event strange taste in the back of throat was recovered and for the event mucus feeling in the back of throat, it was unknown.  Follow-up attempts are completed. No further information is expected.
SEVERE REACTION; This spontaneous report received from a patient via a company representative via social media  concerned a patient of unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient previously received dose 1 with covid-19 vaccine ad26.cov2.s (Dose number in series 1), (unspecified manufacturer), (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered start therapy date were not reported for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination (Dose number in series 1).  The patient received dose 2 with covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced severe reaction (Dose number in series 2). It was reported as " put your report on VAERS. I had two shots and had to report on VAERS due to the severe reaction. NEVER AGAIN". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe reaction was not reported. This report was non-serious. This case, from the same reporter is linked to 20221237290.
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 01-JUL-2013 (lot # H010915, Expiration Date: 13-FEB-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Expired vaccine administered beyond 12 hours expiration for punctured vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours expiration for punctured vial) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Sep-2021 at 4:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours expiration for punctured vial). On 06-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours expiration for punctured vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.  On 31 Aug 2021 , the vial was initially stored in the refrigerator and on 05 Sep 2021 11 AM  vial was first punctured and kept in refrigerator. The vial did not undergo any previous temperature excursions. The total amount of time the vial was exposed to room temperature was from 06 Sep 2021 9.00 AM until the vial was discarded after 4.30 PM.   This case was linked to MOD-2021-311383 (Patient Link).
I am breastfeeding since my child's birth in January 2021. Later the same evening after getting my second COVID vaccine, I got a clogged milk duct in my left breast that was very severe, causing a lot of engorgement and pain. This same thing happened after my first dose of the COVID vaccine, which was on April 1st and reported to this website. This clogged duct has been a bit worse than the one I got after my first dose.
This spontaneous report as received from a physician assistant refers to a 22 years old female patient. The patient was vaccinated with dose 1 GARDASIL (Lot# and route were not reported) on 13-JAN-2009 and dose 2 (Lot# and route were not reported) in March 2009 (two months later at school) and dose 3 (Lot# and route were not reported) on 24-JUL-2012 (today). No other co-suspects were reported. No concomitant medications were reported. No adverse effect had been observed or reported. Additional information has been requested.
began w/cough starting approx 15 mins p/inject loose, congested cough progressing to tight wheeze; pt became agitated, whining, color remained pink; pt taken to ER;
No Adverse Event; 0.5 ml dose; This spontaneous case was reported by an other health care professional and describes the occurrence of OVERDOSE (0.5 ml dose) and NO ADVERSE EVENT (No Adverse Event) in a 4-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 015H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 19-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced OVERDOSE (0.5 ml dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, OVERDOSE (0.5 ml dose) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for OVERDOSE (0.5 ml dose).    Concomitant medications details were not reported by the reporter. Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment details were not reported by the reporter.
Numbness in the right side of the face, right foot, leg , and right arm after 2nd booster; This spontaneous case was reported by a patient and describes the occurrence of HYPOAESTHESIA (Numbness in the right side of the face, right foot, leg , and right arm after 2nd booster) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001M21A and 065F21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (long before vaccination).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA (Numbness in the right side of the face, right foot, leg , and right arm after 2nd booster). At the time of the report, HYPOAESTHESIA (Numbness in the right side of the face, right foot, leg , and right arm after 2nd booster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2022, Magnetic resonance imaging head: normal (normal) did not reveal anything..         No concomitant medications were reported. Patient reported as not having a medical history of Bell's Palsy. She stated that the vaccine did not affect her blood pressure.   Patient took first booster on 12 NOV 2021. After the 2nd booster on 13 APR 2022, the same symptoms came back. She visited a neurologist and did MRI of brain. She stated that she visited her cardiologist too and he did not find anything. No treatment details were reported.   This case was linked to MOD-2022-546579 (Patient Link).
Moderna booster provided after hospital reported that she had not received her booster following looking up in Immunization system.  Upon return RN/staff entered in immunization system and found 3 previously administered doses. RN notified supervisor immediately and report completed.  Phone call to RN at hospital to follow up for adverse affects and notify of extra dose received. Could only leave a message.  Will follow up with hospital and ask them to coordinate a follw up with medical staff.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 19-FEB-2015, the patient was vaccinated with an improperly stored dose of M-M-R II 0.5ml, (HSA, lot # J006995, expiration date 14-JUN-2015). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion eight times. The total cumulative excursion time of the first time was 160 hours with highest recorded temperature of 10 Fahrenheit degree. The total cumulative excursion time of the second time was 344 hours with the highest recorded temperature of 6 Fahrenheit degree. The total cumulative excursion time of the third time was 40 hours with the highest recorded temperature of 8 Fahrenheit degree. The total cumulative excursion time of the fourth time was 64 hours with the highest recorded temperature of 17 Fahrenheit degree. The total cumulative excursion time of the fifth time was 40 hours with the highest recorded temperature of 47 Fahrenheit degree. The total cumulative excursion time of the sixth time was 176 hours with the lowest recorded temperature of 32 Fahrenheit degree. The total cumulative excursion time of the seventh time was 48 hours with the lowest recorded temperature of 34 Fahrenheit degree. The total cumulative excursion time of the eighth time was 72 hours with the lowest recorded temperature of 28 Fahrenheit degree. The storage criteria were refrigerator/freezer (R/F) and the type of excursion for this vaccine (from 1st time to fourth time) was freezer (F); the type of excursion for this vaccine (from the fifth time to eighth time) was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
5/24/09 experienced swelling in the lymph node of the left armpit.  5/25/09 chills, generalized malaise, Temp 99.8  5/26/09 Malaise continued, fever at night 100.2  5/27/09 fever gone, feeling better, able to do ADLs without any problems.
3 Hours after administration began swelling and tender to touch - 6 hours after administration. Started fever. 24 hours after red and still tender.
The day after receiving the second COVID-19 vaccine, I had a massive headache, to the point where I stayed in bed and slept all day.   I also noticed that my brain was foggy.  The next day I was able to move to the couch, but the headache was still severe with continued brain fog.  I called by PCP to see if there was anything that I needed to be doing or taking and she told me that I should start feeling better the next week.   The headache remains but is mild.  I have memory loss and difficulty concentrating.  I am a nurse and over my weekend at work, I had difficulty doing my job because I couldn't keep track of what I was supposed to be doing and had difficulty charting.  My coworkers even commented that I seemed "really different", that my memory was poor, I had personality changes (according to one person) and that my standard of care was much less than usual.  One person also commented that seemed to not be able to hear her and kept asking her to repeat herself.  I find myself having to concentrate harder to see when I am reading or typing something.  I missed work on January 14 and 15 because of the mental fogginess and headache.  I thought I was doing better, but I realized that I wasn't when I returned to work on January 23 and 24.  I have spoken to my PCP on the phone once and am awaiting calls from my PCP and neurologist regarding this event.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients. Medical assistant reported that an unspecified number of patients were administered doses of LIQUID PEDVAXHIB (lot #, expiry date, dose, frequency, route and indication not reported) from 27-JAN-2014 to 24-FEB-2014 after being exposed to temperatures outside of the prescribed information that were not supported. No adverse events were reported. This is one of several reports received from the same source. Addition information has been requested.
They came one after another for about 36 hrs. then cleared up. Sore arm lasted 3 - 4 days.  Very sore arm, mild fever (100.5), headache, body aches, weakness/sleepiness, chills, mild mental fuzziness
Stuffy nose, cough congestion.  Fever the next day of 103.  Extreme fatigue, muscle aches, eye pain.  Runny nose.  Fever is on its 4th day.  Missed school 2 days posibly more.  It appears she has gotten the flu from the vaccine.
Awoke the morning of April 9th with the following: stomach cramps; chest or heart palpitations (left side); significant ringing in both ears (tinnitus). The cramps and palpitations went away within 24-48 hours; the tinnitus has stayed the same for the last 3+ weeks.
Intense muscular pain, whole body fatigue, night sweats, inability to sleep, severe light headedness-nearly fainting, trouble standing, dry heaving